SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VaxGen Inc.-The 1st AIDS Vaccine in Phase 3 HumanTrials -- Ignore unavailable to you. Want to Upgrade?

To: Dave Budde who wrote (57)7/3/1999 2:54:00 PM
From: Tim Davies  Read Replies (1) | Respond to of 250
 
is the stock onthe market yet ?
tim



To: Dave Budde who wrote (57)7/3/1999 2:54:00 PM
From: EmuGreg  Read Replies (1) | Respond to of 250
 
Dave, thank you for your insight. Do you know how far along VaxGen is in enrolling the participants in the Phase III trials. I guess since the study is double-blind, it will be hard to get any vibes on how the vaccine is performing from presentations etc. by the participating Drs.

Thanks for your help.
Greg


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News